Understanding the path to a proper diagnosis of congenital adrenal hyperplasia is crucial for managing this lifelong condition. From newborn screening to detailed blood tests, diagnostic tools help identify hormone imbalances early and guide treatment decisions. Whether you’re a parent of a newborn or an adult experiencing symptoms, knowing what to expect from the diagnostic process can bring clarity and confidence to your healthcare journey.

Introduction: Who Needs Testing and When to Seek Diagnosis

Congenital adrenal hyperplasia is a group of inherited conditions that affect the adrenal glands, small organs positioned on top of each kidney that produce vital hormones. These hormones help regulate stress response, blood pressure, salt and water balance, and sexual development. When the adrenal glands cannot produce these hormones properly due to a missing or faulty enzyme, serious health problems can develop if left untreated.^[1]

The need for diagnostic testing depends on several factors. In many developed countries, every newborn undergoes routine screening for the most severe forms of this condition during the first few days of life. This early testing is critical because classic congenital adrenal hyperplasia, the more serious form, can cause life-threatening complications in infants if not detected and treated promptly. The screening helps identify babies who need immediate medical attention before dangerous symptoms appear.^[4]

However, not all cases are caught at birth. Some individuals have a milder form called nonclassic congenital adrenal hyperplasia, which may not show symptoms until childhood, adolescence, or even adulthood. Children might be referred for testing if they show signs of early puberty, rapid growth followed by shorter-than-expected height, or unusual development. In females, abnormal development of the external genitals at birth is often the first visible sign that prompts immediate testing.^[2]

Adults should consider seeking diagnostic evaluation if they experience persistent fatigue, problems with blood pressure regulation, irregular menstrual periods in women, difficulty with fertility, or signs of excess male hormones such as severe acne or excessive facial and body hair in women. These symptoms might indicate undiagnosed nonclassic congenital adrenal hyperplasia that has gone undetected since childhood.^[2]

Parents who have had one child diagnosed with congenital adrenal hyperplasia or who have a family history of the condition should discuss testing with their healthcare provider, especially if planning future pregnancies. Because this is an inherited condition passed down in families through specific genetic patterns, knowing your family history can help determine whether prenatal testing or early newborn monitoring is advisable.^[6]

Diagnostic Methods: How Doctors Identify Congenital Adrenal Hyperplasia

Newborn Screening

In the United States and many other countries, newborn screening for congenital adrenal hyperplasia is performed routinely during the first few days after birth. This screening uses a small amount of blood collected from the baby’s heel, often as part of a larger panel of tests for various genetic conditions. The process is quick and causes only brief discomfort to the newborn.^[4]

During screening, laboratory equipment measures the level of a substance called 17-hydroxyprogesterone (often abbreviated as 17-OHP) in the baby’s blood. This substance builds up when the body cannot produce enough cortisol, one of the key hormones affected in congenital adrenal hyperplasia. Babies with high levels of 17-OHP might have the condition and require additional testing to confirm the diagnosis.^[4]

It’s important to understand that newborn screening primarily detects the classic forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, which is the most common type accounting for over 90% of cases. The screening test does not identify the milder nonclassic form, which typically appears later in life. Additionally, premature infants or those tested very early may sometimes show elevated results that turn out to be false positives, requiring follow-up testing for confirmation.^[4]

Prenatal Testing

For families with a known history of congenital adrenal hyperplasia or when a previous child has been diagnosed, testing can be performed before birth. Two main procedures are available for prenatal diagnosis. Amniocentesis involves using a needle to remove a sample of the fluid surrounding the fetus in the womb, called amniotic fluid. Laboratory specialists then examine the cells in this fluid to check for genetic changes associated with congenital adrenal hyperplasia.^[6]

The second option is chorionic villus sampling, which involves removing cells from the placenta, the organ that provides the fetus with oxygen and nutrients during pregnancy. A laboratory checks the sample of placenta cells for the genetic mutations that cause congenital adrenal hyperplasia. Both procedures carry small risks, so they are typically only recommended when there is a specific reason to suspect the condition based on family history.^[6]

Physical Examination

When congenital adrenal hyperplasia is suspected in infants, children, or adults, healthcare professionals begin with a thorough physical examination. This typically includes checking blood pressure and heart rate, as the condition can affect cardiovascular function due to hormone imbalances. The doctor will also review any symptoms the patient or parents have noticed.^[15]

In female infants, doctors pay special attention to the appearance of the external genitals. High levels of male hormones (androgens) during fetal development can cause the outer genitals to look different than typical female anatomy, ranging from mild enlargement of the clitoris to appearance that more closely resembles male genitals. This finding often prompts immediate additional testing.^[2]

For female infants whose outer genitals appear atypical, doctors may order additional specialized tests. These include checking the chromosomes, which are structures inside cells that contain genes, to confirm the genetic sex of the baby. An ultrasound examination of the pelvis can also identify the presence of internal female reproductive organs such as the uterus and ovaries, helping to distinguish congenital adrenal hyperplasia from other conditions affecting sexual development.^[6]

Blood and Urine Tests

Blood and urine tests form the cornerstone of diagnosing congenital adrenal hyperplasia beyond newborn screening. These tests measure the levels of various hormones produced by the adrenal glands to identify which ones are too high or too low. The specific hormone imbalances help doctors determine whether congenital adrenal hyperplasia is present and what type the patient has.^[15]

One of the key measurements is the level of 17-hydroxyprogesterone, the same substance checked in newborn screening. Persistently elevated levels of this hormone strongly suggest congenital adrenal hyperplasia. However, a single elevated result doesn’t always confirm the diagnosis, as stress, illness, or premature birth can temporarily raise these levels. Therefore, doctors often repeat testing or perform additional hormone measurements to be certain.^[4]

Healthcare providers also measure cortisol levels, as people with congenital adrenal hyperplasia typically cannot produce enough of this crucial hormone. Low cortisol combined with high 17-hydroxyprogesterone is characteristic of the condition. Additionally, doctors check levels of aldosterone, another hormone that helps regulate salt and water balance in the body, to determine whether the patient has the salt-wasting form of classic congenital adrenal hyperplasia.^[2]

Measurements of male hormones (androgens) such as testosterone help assess the degree of hormone overproduction occurring in the adrenal glands. In congenital adrenal hyperplasia, the body attempts to compensate for low cortisol and aldosterone by ramping up hormone production, but this process inadvertently creates too many androgens. The pattern and levels of these various hormones together create a diagnostic picture that helps doctors confirm congenital adrenal hyperplasia and distinguish it from other adrenal conditions.^[2]

Genetic Testing

Genetic testing can definitively confirm a diagnosis of congenital adrenal hyperplasia by identifying specific mutations in the genes responsible for making enzymes the adrenal glands need. The most common genetic change affects the CYP21A2 gene, which provides instructions for making an enzyme called 21-hydroxylase. Deficiency of this enzyme causes more than 90% of congenital adrenal hyperplasia cases.^[5]

Understanding the specific genetic mutations present helps doctors predict how severe the condition will be and whether complications are likely. Some mutations completely prevent enzyme production, leading to classic congenital adrenal hyperplasia with severe symptoms. Other mutations only partially reduce enzyme activity, resulting in the milder nonclassic form. Genetic testing results also help families understand the risk of having additional children with the condition.^[5]

Additional Imaging Studies

In certain situations, imaging tests provide valuable information to support the diagnosis or assess related complications. An ultrasound of the pelvis, which uses sound waves to create pictures of internal organs, can confirm the presence of a uterus and ovaries in female infants with atypical genital development. This helps distinguish congenital adrenal hyperplasia from other genetic conditions.^[6]

As patients with congenital adrenal hyperplasia grow older, particularly males, doctors may use ultrasound to examine the testicles. The condition can sometimes lead to the development of masses called testicular adrenal rest tumors, which are collections of adrenal-like tissue that grow in the testicles. Regular monitoring with ultrasound helps detect these growths early so appropriate treatment adjustments can be made.^[11]

Diagnostics for Clinical Trial Qualification

Individuals interested in participating in clinical trials for congenital adrenal hyperplasia must undergo specific diagnostic evaluations to determine if they meet the study requirements. Clinical trials are research studies that test new treatments or approaches to managing the condition. Each trial has specific criteria for who can participate, and diagnostic tests help researchers ensure participants are appropriate for the study being conducted.^[10]

Before enrolling in a clinical trial, potential participants typically need comprehensive hormone testing to document their current levels of cortisol, aldosterone, 17-hydroxyprogesterone, and androgens. These baseline measurements establish the severity of hormone imbalances and provide comparison points for measuring whether experimental treatments are working. Blood tests may need to be performed at specific times of day, as some hormones fluctuate throughout the day, and researchers want consistent measurements.^[8]

Genetic testing to identify the specific mutations in the CYP21A2 gene or other genes associated with congenital adrenal hyperplasia is often required for clinical trial enrollment. Some studies focus on particular genetic variants, so knowing exactly which mutations a person carries determines eligibility. This information helps researchers understand whether different genetic types respond differently to experimental treatments.^[10]

Clinical trials may also require documentation of how well current treatments are controlling the condition. This involves regular monitoring of hormone levels over weeks or months before enrollment to show the pattern of control. Researchers want to understand whether participants are adequately managed on standard treatments or if they continue to experience hormone imbalances despite medication. This information helps identify who might benefit most from new therapeutic approaches being studied.^[9]

Additional assessments specific to trial goals might be needed. For example, studies investigating treatments to improve adult height in children would require bone age X-rays and growth measurements. Trials examining fertility treatments might require specialized hormone tests related to reproductive function. Studies focused on metabolic complications could require tests measuring blood sugar, bone density, or body composition. The research team explains all required tests when discussing trial participation.^[11]

Throughout participation in a clinical trial, ongoing diagnostic monitoring continues to track how participants respond to the experimental treatment. This typically involves regular blood and urine collections at scheduled intervals, sometimes weekly or monthly depending on the study design. These repeated measurements allow researchers to see whether the new treatment successfully improves hormone balance compared to standard care. Participants should expect more frequent testing during trials than they would experience with routine clinical care.^[9]